© 2019 Peptilogics  I  All Rights Reserved

News & Updates

Peptilogics is attending the 37th Annual J.P. Morgan Healthcare Conference on January 7-10, 2019

Thiel joins leading investors Stefan Roever and BlueTree Ventures in Series A round Company appoints Sanjay Kakkar as Chief Executive Officer

Peptilogics, a pre-clinical stage company utilizing an innovative peptide platform to treat multidrug-resistant bacterial infections, announced today that it closed a $5.5 million Series A financing with participation from Peter Thiel, Stefan Roever, BlueTree Ventures and others. Peptilogics, founded by Jonathan Steckbeck, who serves as President and Chief Scientif...

Please reload